Robert S. Salcido
Partner
Areas of Focus
- False Claims Act/Qui Tam Defense
- Fraud & Abuse Compliance and Litigation
- Health Care Regulatory Compliance Counseling
- Health Care & Life Sciences
- Health Care Litigation & Investigations
- Claims, Disputes & Litigation
- Inspector General Investigations
- Represents Fortune 500 companies, major nonprofit health care systems and executives in responding to governmental civil and criminal investigations.
- One of the few lawyers who has successfully litigated multiple FCA actions against the government at trial and at summary judgment.
- Has authored an extensive (1050 pages) FCA treatise and more than 30 articles and spoken at more than 70 conferences regarding the scope and application of the FCA and health care fraud and abuse laws.
- Recognized by multiple publications for prevailing in several high stakes FCA lawsuits.
Robert represents clients in False Claims Act (FCA) and qui tam litigation and provides counseling regarding the application of health care fraud and abuse laws. As lead counsel, he has successfully defended a number of FCA actions by obtaining the dismissal of the lawsuit on appeal, at trial, at summary judgment and at the pleading stage.
Robert has authored books and multiple articles, including several cited in court decisions, regarding the FCA and health care fraud and abuse laws. Robert has lectured extensively on defenses to FCA actions; health care coding compliance; and FCA whistleblower litigation, including national conferences sponsored by the American Bar Association, the American Health Law Association and the Health Care Compliance Association.
Prior to joining Akin, Robert was a trial attorney with the U.S. Department of Justice in the Civil Fraud Unit from 1988 to 1993. He prosecuted cases under the FCA, handled cases under the FCA’s voluntary disclosure provisions and concentrated on whistleblower actions brought under the qui tam provisions of the FCA.
Click here for a full list of Robert’s written works, including books, chapters in books and articles.
Robert has successfully defended FCA actions at trial, summary judgment, appeal and at the pleading stage.
- Represented Golden Living in an FCA action where the federal government had sued Golden Living’s predecessor company, Beverly Enterprises, for $895 million, alleging that Beverly had engaged in an unlawful kickback scheme with McKesson Corp. in violation of the Anti-Kickback Act and the FCA. After 14 days of trial, the court ruled that Beverly and McKesson did not violate the FCA or the Anti-Kickback Act because their business negotiations were fair, reasonable and conducted in good faith. Reported Decision: United States of America ex rel. Jamison v. McKesson Corp., 900 F. Supp. 2d 683 (N.D. Miss. 2012).
Recent Successful FCA Actions at Summary Judgment
- Represented Aegis Therapies (a rehabilitation therapy company) and a Golden Living skilled nursing facility (SNF) where the federal government had alleged that defendants provided medically unnecessary rehabilitation therapy. The district court granted defendants’ summary judgment motion. Reported Decision: United States ex rel. Lawson v. Aegis Therapies, Inc., 2015 U.S. Dist. LEXIS 45221 (S.D. Ga. Mar. 31, 2015).
- Represented a physician and multispecialty group practice that the government accused of providing medically unnecessary services. The district court dismissed all of the government’s claims on summary judgment. Ultimately, because the United States’ action lacked “substantial justification,” the U.S. was ordered to pay defendants more than $400,000 in legal fees. In making the ruling, the court ruled that Medicare fraud law is an area of expertise and that it was undisputed that Robert possessed such expertise. Reported Decision: United States v. Prabhu, 442 F. Supp. 2d 1008 (D. Nev. 2006).
- Represented Golden Living in an action where relator and government sued multiple defendants alleging that they violated the FCA because they knowingly created and operated a supply company in violation of Medicare Supplier Standards. The district court granted defendants’ summary judgment motion regarding the Supplier Standards allegations, finding that the government’s prior administrative proceedings demonstrated that the defendant supply company was entitled to payment. Reported Decision: United States of America ex rel. Jamison v. McKesson Corporation, 784 F. Supp. 2d 664 (N.D. Miss. 2011).
- Represented Huron Consulting Group in a qui tam action alleging that Huron caused St. Vincent’s Catholic Medical Centers to inflate its charges to obtain an unlawfully excessive amount of Medicare outlier payments. At summary judgment, the court dismissed plaintiff’s claim, ruling that there could be no FCA violation as a matter of law because the alleged practice—raising charges on the chargemaster, which resulted in the receipt of additional outlier payments—”was not forbidden by either regulation or standard practice.” Reported Decision: United States ex rel. Assoc. Against Outlier Fraud v. Huron Consulting Grp., Inc., 929 F. Supp. 2d 245 (S.D.N.Y. 2013).
EducationJ.D., Harvard Law School, 1988
B.A., Claremont McKenna College, 1984
J.D., Harvard Law School, 1988
B.A., Claremont McKenna College, 1984
Bar AdmissionsCalifornia
District of Columbia
California
District of Columbia
Robert has won extensive recognition for FCA litigation success:
- Best Lawyers in America, 2021-2022.
- BTI Consulting Group, Client Service All-Star, based on in-depth interviews with general counsel and recognizes lawyers identified as “delivering the absolute best levels of client service,” 2020
- National Law Journal, inaugural list of Health Care Law Trailblazers, recognizing those who have made an impact through new strategies or innovative court cases for several notable FCA wins, 2019.
- National Law Journal, Winning Litigators, chosen for their “great results for clients in high stakes matters” for obtaining a successful trial verdict in an FCA lawsuit, 2018.
- Chambers USA: America’s Leading Lawyers for Business, Healthcare: Regulatory & Litigation, Leading Individuals, Nationwide, Band 1; Healthcare Leading Individuals, District of Columbia, Band 1, 2011-2019; Healthcare, District of Columbia, Band 1, 2020-2024.
- National Law Journal, Litigation Trailblazers & Pioneers, one of 50 “people who have made a difference in the fight for justice” for his outstanding work in defending FCA lawsuits, 2014.
- Law360, one of the four Health Care MVPs, based upon a successful trial verdict obtained in defense of a national skilled nursing facility chain in an $895 million FCA lawsuit the government filed, 2012.
- Super Lawyers, Washington. D.C., Health Care, 2008-2011 and 2013-2020.
Robert also won awards for his governmental service, including:
- U.S. Department of Health and Human Services Office of Inspector General (OIG), Integrity Award, highest award OIG bestows to individuals outside of the OIG, 1993.
- U.S. Department of Justice, Special Achievement Award, for Sustained Superior Performance of Duty, 1992.
- U.S. Department of Justice, Special Achievement Award, for Sustained Superior Performance of Duty, 1991.
- “Legal Update: What’s Old Is New Again. Constitutionality, Scienter, Falsity, Causation, Government Dismissal Authority and More,” Civil False Claims 2024, American Bar Association National Virtual Institutes, June 4, 2024.
- “Trending Defenses to Contest False Claims Act, Stark, Kickback Allegations,” American Health Law Association Fraud and Compliance Forum, September 28, 2023.
- “False Claims Act Litigation Update,” American Health Law Association Annual Meeting, June 26, 2023.
- “AseraCare’s Aftermath and Other Trending False Claims Act Defenses Related to Government Investigations and Litigation Against Long Term and Post-Acute Care Providers,” American Health Law Association Long Term and Post-Acute Care Law and Compliance 2023, March 2, 2023.
- “Health Care Fraud and Abuse: 2022 False Claims Act Update,” American Health Law Association, October 19, 2022.
- “False Claims Act Update,” American Health Law Association Fraud and Compliance Forum, September 28-30, 2022.
- “Hot topics 2022: Focus on Infrastructure and Pandemic Relief Funds,” American Bar Association Virtual Civil False Claims Act and Qui Tam Enforcement Institute, September 12-14, 2022.
- “Efficiently and Effectively Managing Government Law Enforcement Investigations,” American Health Law Association In-House Counsel Program, June 26, 2022.
- “FCA Activity Surrounding Nursing Homes, Skilled Nursing Facilities, and Hospice Care: Unwritten Lessons for Life Sciences & Healthcare Companies,” ACI’s Virtual False Claims and Qui Tam Summit for Life Sciences and Healthcare, September 24, 2021.
- “Hot Topics in Fraud and Abuse,” The American Law Association Virtual Annual Meeting, June 29, 2021.
- “Interactive Ethical Considerations for the FCA Litigator,” ACI’s 8th Annual Forum on False Claims and Qui Tam Enforcement, March 21, 2021.
- “Cutting Edge Issues Regarding False Claims Act, Stark, Kickback Allegations,” The American Health Law Association’s Virtual Annual Fraud and Abuse Conference, October 1, 2020.
- “Fraud Hot Topics,” American Health Law Association Annual Meeting, June 30, 2020.
- "Significant False Claims Act Case Law Developments and Preparing for FCA Enforcement in the Post-COVID-19 World,” American Health Law Association Webinar, May 27, 2020.
- “Qui Tam Settlements – Latest Trends,” The Healthcare Roundtable, September 11-13, 2019.
- “Department of Justice’s Evolving Civil Enforcement Priorities,” Congressional Civil Justice Academy, February 22, 2019.
- "Health Care Enforcement and the False Claims Act (FCA) – Industry Trends and Legal Developments,” Southeastern White Collar Crime Institute, September 5-7, 2018.
Click here for a full list of conferences at which Robert has spoken.